Variables Reflecting the Mineralization of Bone Tissue From Fracturing Versus Nonfracturing Postmenopausal Nonosteoporotic Women

Abstract

Women with equivalent areal bone mineral densities may show a different fracture incidence due to differences in bone intrinsic quality. Previously, Fourier transform infrared spectroscopic imaging (FTIRI) on the same iliac bone biopsies reported here, showed that the only significantly different variable was the carbonate/phosphate ratio, which was decreased in the fracturing group. Nanoindentation showed that fracturing bone was less mechanically heterogeneous than nonfracturing bone and could propagate damage (microcracks) more easily. The hypothesis is that fracturing women have reduced mineralization of bone tissue compared to nonfracturing women. Transiliac bone biopsies were collected from fracturing (n = 60, 62.5 ± 7.4 years old) and nonfracturing (n = 60, 62.3 ± 7.3 years old) postmenopausal women, to assess the mineralization of bone tissue using digitized microradiography. The degree of mineralization of bone (DMB, g/cm3) and the heterogeneity index (HI, g/cm3) of the DMB were calculated for cancellous (canc), cortical (cort) and total bone. Results were compared to variables from nanoindentation, FTIRI, and histomorphometry. DMB and HI were not significantly different between fracturing and nonfracturing groups. In the nonfracturing group, cort and canc HI were weakly negatively associated with cort and canc DMB (r′ = −0.388, p < 0.003; r′ = −0.532, p < 0.0001, respectively). In the fracturing group, DMB and HI were negatively correlated only in canc (r′ = −0.295, p = 0.024). DMB and HI were not associated with nanoindentation variables. Cort and canc DMB were positively associated with mineral‐to‐matrix ratio measured by FTIRI (ratio between mineral and organic matrix representing the relative mineralization of the collagen matrix), and negatively associated with carbonate/phosphate ratio. None of the DMB variables were strongly associated with any of the histomorphometric variables. In conclusion, bone mineralization was not significantly different between fracturing and nonfracturing postmenopausal women, suggesting that bone fragility could be partly due to other variables, such as changes in hydration of bone matrix or an increase of non‐enzymatic crosslinks in bone collagen. © 2018 The Authors. JBMR Plus published by Wiley Periodicals, Inc. on behalf of American Society for Bone and Mineral Research.

Inhibition of vascular endothelial growth factor in young adult mice causes low bone blood flow and bone strength with no effect on bone mass in trabecular regions

“…Half of all fragility fractures occur in individuals with osteopenia (BMD T-score < −1.0, but >−2.5), rather than osteoporosis (T-score < −2.5) ( Kanis et al, 1994 ; Fonseca et al, 2014 ). As with GC and diabetic patients, studies of bone blood flow in BMD-matched osteopenic patients who have (or have not) experienced fragility fractures, could be used to examine the relationship of bone blood flow to excessive bone fragility ( Rizzo et al, 2018 ; Polly et al, 2012 ).…”

miR-4739/ITGA10/PI3K signaling regulates differentiation and apoptosis of osteoblast

“…Meanwhile, many crucial biological processes were strongly associated with miRNAs, such as cell differentiation, apoptosis, as well as proliferation [ 15 ]. Some research showed that certain miRNAs can be involved in bone metabolism, bone turnover as well as bone development, so as to regulate the occurrence and progress of OP [ 16 ]. A study have shown that miR-133 expression is increased during estrogen deficiency, regulating osteogenic differentiation of mesenchymal stem cells, and causing postmenopausal OP [ 17 ].…”

miR‑205 regulates bone turnover in elderly female patients with type 2 diabetes mellitus through targeted inhibition of Runx2

“…OP is one of the common complications of patients with type 2 diabetes mellitus (T2DM), causing great morbidity and seriously affecting the quality of life of patients ( 2-4 ). Currently, the main therapeutic methods for elderly patients with T2DM and OP include calcium and vitamin D supplements, physical exercise, specified diet and high quality nursing, yet the occurrence and progression of OP in elderly patients with T2DM cannot be effectively controlled ( 5 , 6 ). Therefore, it is of great clinical significance to explore new therapeutic methods and drugs for patients with T2DM and OP.…”